| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
|
N Engl J Med
|
1999
|
6.93
|
|
2
|
Access to coronary artery bypass surgery by race/ethnicity and gender among patients who are appropriate for surgery.
|
Med Care
|
1999
|
3.07
|
|
3
|
Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry.
|
Am J Cardiol
|
1992
|
2.08
|
|
4
|
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.
|
Circulation
|
1999
|
1.82
|
|
5
|
Percutaneous laser thermal angioplasty: initial clinical results with a laser probe in total peripheral artery occlusions.
|
Lancet
|
1986
|
1.72
|
|
6
|
Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells.
|
J Clin Invest
|
1997
|
1.69
|
|
7
|
Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
|
J Am Coll Cardiol
|
2000
|
1.66
|
|
8
|
Expanded indications for laser-assisted balloon angioplasty in peripheral arterial disease.
|
J Vasc Surg
|
1990
|
1.62
|
|
9
|
Novel distal occluder washout method for prevention of no-reflow during stenting of saphenous vein grafts.
|
Catheter Cardiovasc Interv
|
1999
|
1.39
|
|
10
|
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart.
|
J Thorac Cardiovasc Surg
|
1998
|
1.37
|
|
11
|
Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels.
|
Lancet
|
2000
|
1.22
|
|
12
|
Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.
|
J Clin Invest
|
1995
|
1.18
|
|
13
|
Dietary and hormonal regulation of hepatic biosynthetic and catabolic enzymes of serine metabolism in rats.
|
Endocrinology
|
1972
|
1.12
|
|
14
|
The history of interventional cardiology: cardiac catheterization, angioplasty, and related interventions.
|
Am Heart J
|
1995
|
1.09
|
|
15
|
Experimental angioplasty: circumferential distribution of laser thermal energy with a laser probe.
|
J Am Coll Cardiol
|
1985
|
1.06
|
|
16
|
Human percutaneous and intraoperative laser thermal angioplasty: initial clinical results as an adjunct to balloon angioplasty.
|
J Vasc Surg
|
1987
|
1.02
|
|
17
|
Platelet accumulation in experimental angioplasty: time course and relation to vascular injury.
|
Circulation
|
1987
|
1.00
|
|
18
|
Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry.
|
Am Heart J
|
2001
|
1.00
|
|
19
|
Angiographic and histologic consequences of laser thermal angioplasty: comparison with balloon angioplasty.
|
Circulation
|
1987
|
0.99
|
|
20
|
The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance.
|
J Mol Cell Cardiol
|
1999
|
0.98
|
|
21
|
Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.
|
Ann Thorac Surg
|
2000
|
0.97
|
|
22
|
Percutaneous coronary laser thermal angioplasty.
|
J Am Coll Cardiol
|
1986
|
0.97
|
|
23
|
Laser angioplasty for limb salvage: observations on early results.
|
J Vasc Surg
|
1989
|
0.95
|
|
24
|
Reduction in angioplasty complications after the introduction of coronary stents: results from a consecutive series of 2242 patients.
|
Am Heart J
|
1996
|
0.93
|
|
25
|
Transluminal angioplasty in experimental atherosclerosis. Analysis for embolization using an in vivo perfusion system.
|
Circulation
|
1982
|
0.93
|
|
26
|
Specific inhibition of eIF-5A and collagen hydroxylation by a single agent. Antiproliferative and fibrosuppressive effects on smooth muscle cells from human coronary arteries.
|
J Clin Invest
|
1995
|
0.93
|
|
27
|
Effect of antiplatelet therapy on restenosis after experimental angioplasty.
|
Am J Cardiol
|
1984
|
0.91
|
|
28
|
Coronary artery perforation during excimer laser coronary angioplasty. The percutaneous Excimer Laser Coronary Angioplasty Registry.
|
J Am Coll Cardiol
|
1993
|
0.89
|
|
29
|
Restenosis following transluminal angioplasty in experimental atherosclerosis.
|
Arteriosclerosis
|
1984
|
0.89
|
|
30
|
Early limitations of coronary excimer laser angioplasty.
|
J Am Coll Cardiol
|
1991
|
0.85
|
|
31
|
Percutaneous transluminal coronary angioplasty of a right coronary artery arising from the left main coronary artery.
|
Cathet Cardiovasc Diagn
|
1993
|
0.82
|
|
32
|
Balloon optimization versus stent study (BOSS): provisional stenting and early recoil after balloon angioplasty.
|
Am J Cardiol
|
2000
|
0.81
|
|
33
|
Mechanism of angioplasty and its relation to restenosis.
|
Am J Cardiol
|
1987
|
0.81
|
|
34
|
Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry.
|
Am J Cardiol
|
1994
|
0.80
|
|
35
|
Acute complications of excimer laser coronary angioplasty: a detailed analysis of multicenter results. Coinvestigators of the U.S. and European Percutaneous Excimer Laser Coronary Angioplasty (PELCA) Registries.
|
J Am Coll Cardiol
|
1994
|
0.80
|
|
36
|
The mechanism of transluminal angioplasty: evidence for formation of aneurysms in experimental atherosclerosis.
|
Circulation
|
1983
|
0.79
|
|
37
|
Excimer laser-facilitated coronary angioplasty. Relative risk analysis of acute and follow-up results in 200 patients.
|
Circulation
|
1992
|
0.79
|
|
38
|
Acute biologic response to excimer versus thermal laser angioplasty in experimental atherosclerosis.
|
J Am Coll Cardiol
|
1991
|
0.78
|
|
39
|
Early and late quantitative angiographic results of vein graft lesions treated by excimer laser with adjunctive balloon angioplasty.
|
Circulation
|
1995
|
0.78
|
|
40
|
Serial angiographic evidence of rapid resolution of coronary artery stenosis.
|
Chest
|
1983
|
0.77
|
|
41
|
Regulation of enzymes of serine and one-carbon metabolism by testosterone in rat prostate, liver, and kidney.
|
Endocrinology
|
1975
|
0.77
|
|
42
|
Immediate sealing of arterial puncture sites after cardiac catheterization and coronary angioplasty using a biodegradable collagen plug: results of an international registry.
|
J Am Coll Cardiol
|
1993
|
0.76
|
|
43
|
Intraoperative angioscopy of saphenous vein and coronary arteries.
|
J Thorac Cardiovasc Surg
|
1986
|
0.76
|
|
44
|
Response. Peripheral laser angioplasty: need for organized clinical trials.
|
Radiology
|
1989
|
0.75
|
|
45
|
Primary success, long-term patency, reporting standards, and indications for peripheral angioplasty devices.
|
Circulation
|
1991
|
0.75
|
|
46
|
Technical success, clinical success, and patency in laser angioplasty.
|
Radiology
|
1989
|
0.75
|
|
47
|
Laser thermal angioplasty: from the experimental model to early human experience.
|
Trans Am Clin Climatol Assoc
|
1987
|
0.75
|
|
48
|
Percutaneous peripheral atherectomy: what are its indications?
|
J Am Coll Cardiol
|
1990
|
0.75
|
|
49
|
Analysis of late lumen narrowing after excimer laser-facilitated coronary angioplasty.
|
J Am Coll Cardiol
|
1994
|
0.75
|
|
50
|
Coronary laser thermal angioplasty in the swine: reduced complications with shorter laser delivery time.
|
J Interv Cardiol
|
1991
|
0.75
|
|
51
|
Laser angioplasty: peripheral and coronary applications.
|
Cardiovasc Clin
|
1988
|
0.75
|
|
52
|
Cholesterol after angioplasty.
|
Circulation
|
1982
|
0.75
|
|
53
|
Intracoronary stents.
|
Surg Technol Int
|
1996
|
0.75
|
|
54
|
Bailout stenting for extensive dissection complicating direct infarct angioplasty.
|
Am Heart J
|
1996
|
0.75
|
|
55
|
Excimer laser coronary angioplasty: the New Approaches to Coronary Intervention (NACI) experience.
|
Am J Cardiol
|
1997
|
0.75
|
|
56
|
Excimer laser-facilitated balloon angioplasty of a nondilatable lesion.
|
J Am Coll Cardiol
|
1991
|
0.75
|
|
57
|
Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting.
|
Am J Cardiol
|
1999
|
0.75
|
|
58
|
Wire-guided excimer laser coronary angioplasty: instrument selection, lesion characterization, and operator technique.
|
J Interv Cardiol
|
1992
|
0.75
|
|
59
|
Ventricular entrapment of a Swan-Ganz catheter: a technique for nonsurgical removal.
|
J Am Coll Cardiol
|
1989
|
0.75
|
|
60
|
Experimental argon laser thermal angioplasty as an adjunct to balloon angioplasty in peripheral arteriosclerotic disease.
|
Cathet Cardiovasc Diagn
|
1990
|
0.75
|
|
61
|
The changing profile of patient selection, procedural techniques, and outcomes in excimer laser coronary angioplasty. Participating Investigators of the Percutaneous Excimer Laser Coronary Angioplasty Registry.
|
J Interv Cardiol
|
1995
|
0.75
|
|
62
|
Vascular endoscopy: current state of the art.
|
Br Med Bull
|
1986
|
0.75
|
|
63
|
Percutaneous vascular hemostasis device for interventional procedures.
|
Cathet Cardiovasc Diagn
|
1992
|
0.75
|
|
64
|
Laser catheter thermal angioplasty: technique and early results in 34 patients.
|
AJR Am J Roentgenol
|
1989
|
0.75
|
|
65
|
Management of the arterial puncture site.
|
J Interv Cardiol
|
1994
|
0.75
|
|
66
|
Percutaneous excimer laser coronary angioplasty.
|
Lancet
|
1989
|
0.75
|
|
67
|
Acute biological response to laser balloon angioplasty in the atherosclerotic rabbit.
|
Lasers Surg Med
|
1994
|
0.75
|
|
68
|
Cardiovascular applications of lasers: searching for a niche.
|
J Clin Laser Med Surg
|
1997
|
0.75
|